| pubmed-article:19193575 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19193575 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:19193575 | lifeskim:mentions | umls-concept:C0022661 | lld:lifeskim |
| pubmed-article:19193575 | lifeskim:mentions | umls-concept:C0123931 | lld:lifeskim |
| pubmed-article:19193575 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19193575 | pubmed:dateCreated | 2009-5-1 | lld:pubmed |
| pubmed-article:19193575 | pubmed:abstractText | To observe and report on the pharmacokinetics of irinotecan in a patient with end-stage renal failure (ESRF) who was undergoing hemodialysis. | lld:pubmed |
| pubmed-article:19193575 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19193575 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19193575 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19193575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19193575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19193575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19193575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19193575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19193575 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19193575 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19193575 | pubmed:issn | 1542-6270 | lld:pubmed |
| pubmed-article:19193575 | pubmed:author | pubmed-author:KellerFrieder... | lld:pubmed |
| pubmed-article:19193575 | pubmed:author | pubmed-author:ShipkovaMaria... | lld:pubmed |
| pubmed-article:19193575 | pubmed:author | pubmed-author:CzockDavidD | lld:pubmed |
| pubmed-article:19193575 | pubmed:author | pubmed-author:RascheFranz... | lld:pubmed |
| pubmed-article:19193575 | pubmed:author | pubmed-author:BoeslerBenjam... | lld:pubmed |
| pubmed-article:19193575 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19193575 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:19193575 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19193575 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19193575 | pubmed:pagination | 363-9 | lld:pubmed |
| pubmed-article:19193575 | pubmed:meshHeading | pubmed-meshheading:19193575... | lld:pubmed |
| pubmed-article:19193575 | pubmed:meshHeading | pubmed-meshheading:19193575... | lld:pubmed |
| pubmed-article:19193575 | pubmed:meshHeading | pubmed-meshheading:19193575... | lld:pubmed |
| pubmed-article:19193575 | pubmed:meshHeading | pubmed-meshheading:19193575... | lld:pubmed |
| pubmed-article:19193575 | pubmed:meshHeading | pubmed-meshheading:19193575... | lld:pubmed |
| pubmed-article:19193575 | pubmed:meshHeading | pubmed-meshheading:19193575... | lld:pubmed |
| pubmed-article:19193575 | pubmed:meshHeading | pubmed-meshheading:19193575... | lld:pubmed |
| pubmed-article:19193575 | pubmed:meshHeading | pubmed-meshheading:19193575... | lld:pubmed |
| pubmed-article:19193575 | pubmed:meshHeading | pubmed-meshheading:19193575... | lld:pubmed |
| pubmed-article:19193575 | pubmed:meshHeading | pubmed-meshheading:19193575... | lld:pubmed |
| pubmed-article:19193575 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19193575 | pubmed:articleTitle | Irinotecan in cancer patients with end-stage renal failure. | lld:pubmed |
| pubmed-article:19193575 | pubmed:affiliation | University Hospital Heidelberg, Heidelberg, Germany. david.czock@med.uni-heidelberg.de | lld:pubmed |
| pubmed-article:19193575 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19193575 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19193575 | lld:pubmed |
